Printer Friendly

Browse Generic drugs topic

Laws, regulations and rules subtopic

Articles

1-236 out of 236 article(s)
Title Author Type Date Words
Peru : Minsa will strengthen the regulation of generic medicines. Jan 16, 2018 316
AAM Spotlights Obstacles to Generic Competition. Jan 15, 2018 471
Intellectual Property and Regulatory Law: Recent Developments / Parallel Trade 2018. Nov 8, 2017 425
India's Dodgy Pharmacy. Bate, Roger Essay Nov 1, 2017 15423
Open House Discount Deals 2017-012. Oct 24, 2017 301
GervanoRA Data Services (GDS) Projects Germany's Pharmaceutical Market is the Largest in Europe and is Expected to Reach $63.3 Billion by 2022. Oct 16, 2017 998
GervanoRA Data Services (GDS) Projects Germany's Pharmaceutical Market is the Largest in Europe and is Expected to Reach $63.3 Billion by 2022. Oct 16, 2017 1005
United States : Another McCaskill Bill to Become Law: Plan with Collins to Tackle Cost of Rx Drugs Headed to Presidents Desk. Aug 11, 2017 362
Mallinckrodt Finalizes Previously Announced Agreement with DEA and USAOs. Jul 11, 2017 1676
Legislation targets obstacles for generics. Jun 5, 2017 638
United States : Senate Health Panel Approves Three of Sen. Frankens Provisions as Part of Bipartisan FDA Reform Bill. May 16, 2017 201
Product hopping. Carrier, Michael A. Essay Apr 1, 2017 6163
African pharma will not immediately benefit from WTO's change in intellectual property laws. Feb 6, 2017 287
African pharma will not immediately benefit from WTO's change in intellectual property laws. Feb 6, 2017 291
Overview of Japanese Generic Drug Market 2016: Market Size, Primary Makers, Market Trends, and Updated Situation on Biosimilars and Authorized Generics - Research and Markets. Oct 20, 2016 409
Overview of Japanese Generic Drug Market 2016: Market Size, Primary Makers, Market Trends, and Updated Situation on Biosimilars and Authorized Generics - Research and Markets. Oct 20, 2016 449
Similar, not identical. Cauchi, Dick Aug 31, 2016 364
Malaysia : High-value Specialty Medicine, Biosimilars and Premium Pricing Portfolio Drives Growth in the Global Generic Pharmaceuticals Market. Aug 5, 2016 574
Israel,United States : TEVA hopes to close its deal with ALLERGAN soon upon receipt of FTC nods. Aug 2, 2016 231
Implications of the final AMP rule for community Rx. Shakow, John Jul 25, 2016 1528
House committee praised for action on proposed labeling rule. May 16, 2016 574
As AMP rule takes effect, industry keeps close watch. Apr 18, 2016 829
US Generics Market Report 2016: Why is the US Generics Market so Lucrative? - Research and Markets. Report Apr 14, 2016 597
US Generics Market Report 2016: Why is the US Generics Market so Lucrative? - Research and Markets. Report Apr 14, 2016 637
Top Speakers On CPhI Resources Explore New Laws & Regulations and Technology Trends for Nextgen2016. Mar 30, 2016 640
Top Speakers On CPhI Resources Explore New Laws & Regulations and Technology Trends for Nextgen2016. Mar 30, 2016 624
Antitrust law - "hard switch" a violation of the Sherman Act in "product hopping" case. Lacy, Emily Case note Mar 22, 2016 9034
U.S., Europe get in step on regulation of generics. Mar 14, 2016 412
EU faces tangle of pricing systems in regulation of generics. Feb 22, 2016 650
New Pharmacy Mandates Would Increase Rx Costs, Undermine Competition. Nov 17, 2015 1155
National Senior Care Pharmacy Leader: Arkansas PBM Reform Law Targeting Generic Drug Pricing Abuses Good Model for Other States. Sep 17, 2015 671
Mylan v. Warner Chilcott: a study in pharmaceutical product hopping. Iyengar, Vikram Jun 22, 2015 8617
Generics substitution, bioequivalence standards and oversight of international pharmaceutical producers: Complex issues facing the FDA. Bate, Roger; Mathur, Aparna; Lever, Harry M.; Thakur, Dinesh; Graedon, Joe; Cooperman, Tod; Mason, P Report May 1, 2015 7084
President allows import of generic drugs in Kyrgyzstan. Apr 15, 2015 124
Still awaiting the 'biosimilars' revolution: despite recent efforts, the United States remains a long way from a Hatch-Waxman breakthrough for biologic drugs. Miller, Henry I. Mar 22, 2015 2693
NCPA calls for more transparency. Brief article Jan 19, 2015 130
MPs approve bill allowing to open drug market of Kyrgyzstan for cheap generics. Nov 18, 2014 170
Hepatitis C treatment costs $80,000 in Kyrgyzstan requiring amendments in legislation for supply of cheaper generics. Aug 1, 2014 169
Patent claim construction takes center stage, as usual. Jul 18, 2014 849
FTC files amicus brief in Rx distribution case. Jul 7, 2014 109
Mutual Pharmaceutical Co. v. Bartlett and the demise of recovery for consumers of generic drugs. Masters, Diana J. Jun 22, 2014 9587
Insurers accused of discrimination against HIV-infected. Thomas, Katie May 30, 2014 537
NCPA Commends Medicare Steps on Generic Drug Reimbursement; Urges Congress to Enact Any Willing Pharmacy Law. May 20, 2014 715
Actavis sues FDA for delaying approval of generic Celebrex. May 1, 2014 243
Actavis sues FDA for delaying approval of generic Celebrex. May 1, 2014 239
Reverse-payment patent settlements in the pharmaceutical industry: an analysis of U.S. antitrust law and EU competition law. Clancy, Michael; Geradin, Damien; Lazerow, Andrew Mar 22, 2014 6354
Sector is thriving, but it still faces challenges. Mar 17, 2014 649
Law & medicine: medicolegal aspects of generic drugs. Tan, S.Y. Mar 1, 2014 1255
Generics Drugs, Cheap Medicine laws benefits still limited. Feb 22, 2014 834
Legal defeat for store-brand generics in Canada. Feb 17, 2014 458
NEW ECONOMIC ANALYSIS SHOWS THAT FDA PROPOSED GENERIC DRUG LABELING REGULATION WOULD RESULT IN $4 BILLION IN NEW HEALTH CARE COSTS. Feb 5, 2014 608
LAW & MEDICINE: Medicolegal aspects of generic drugs. Tan, S.Y. Feb 1, 2014 1279
The Generic Pharmaceutical Association (GPhA): Ralph Neas, President and CEO. Neas, Ralph Jan 6, 2014 1176
FDA: Speed generic updates. Anderson, Jane Brief article Dec 1, 2013 147
A First Amendment approach to generic drug manufacturer tort liability. Sullivan, Connor Nov 1, 2013 6782
More Filipinos turning to generic drugs, says DOH. Oct 1, 2013 398
Indian drugmaker Ranbaxy faces new US regulation woes. Sep 16, 2013 502
FDA poised to alter generics labeling regs. Aug 5, 2013 656
PDUFA helps FDA reduce the backlog of ANDAs. Aug 5, 2013 614
FDA rule would allow generic drugmakers to update labels. Jul 5, 2013 289
L.A. Times weighs in on biosimilars. Brief article Apr 22, 2013 253
Generic-drug makers sue brand-name companies for product samples. Apr 4, 2013 327
Defining valuable information in a shifting industry. Bourgoin, Andrew F. Apr 1, 2013 791
Absorption Systems Registers with FDA as a Generic Drug Facility under GDUFA. Mar 25, 2013 869
Understanding generic drugs. Smith, Stephanie Mar 22, 2013 356
Developments may require revision of Hatch-Waxman Act. Feb 18, 2013 564
Watson taps brown to fill key vp post. Sep 24, 2012 361
Generic drug manufacturer liability: achieving a balance between consumer affordability and safety. James, Sarah S. Sep 22, 2012 9104
The China syndrome? The middle kingdom discovers compulsory licensing. Silverman, Ed Jul 1, 2012 1371
Bill aims to fix snag in labeling. May 21, 2012 120
Appeal of ban on chains selling own generics in works. Apr 23, 2012 329
High court ruling is still controversial. Brief article Apr 23, 2012 397
Branham Law Group, LLP Investigates Glenmark Generics for Birth Control Packaging Error. Mar 25, 2012 294
Pliva, Inc. v. Mensing: how generic-drug manufacturers avoided liability for "failure to warn" tort claims. Feeney, Gregory J. Mar 22, 2012 8374
Alacrita Establishes Powerful Regulatory Affairs Practice to Serve Life Science Companies and Investors. Oct 3, 2011 1083
CEO: pharmacy business prospers despite impact of reforms. Aug 29, 2011 911
Assessment margin of concerned member state in European authorization procedure--A small step beyond the ECJ Synthon Judgement. Aug 1, 2011 798
Chartwell Pharmaceuticals Receives Official FDA Registration. Jul 12, 2011 254
EU-Canada trade talks may spark changes to patent law. Sarkis, Marcelo Konig Jun 1, 2011 532
Fda chief touts teamwork. Mar 28, 2011 548
Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers. Rostron, Allen Feb 1, 2011 30757
The Netherlands: policy On use patents for the Registration of generic Medicinal products. Feb 1, 2011 1000
The Generic Pharmaceutical Association (GPhA). Billings, Robert Jan 3, 2011 869
EU health claims update: EFSA has issued more rejections for the latest batch of generic claims. Gruenwald, Joerg Jan 1, 2011 996
Abuse of dominance. Jan 1, 2011 1402
AMP impact 'only limited'. Dec 6, 2010 499
Massachusetts Will Remain A Challenging Environment for Pharmaceutical Companies Due to State Generic Substitution Laws and Disallowance of Coupons. Nov 16, 2010 683
Research and Markets: Generic Drug Product Development: International Regulatory Requirements for Bioequivalence. Oct 20, 2010 288
California dreamin'? Generic drug users can sue brand name drug manufacturers. Martin, Anthony L., Jr. Oct 1, 2010 5125
Generic drugs' star will continue its ascent. Coopman, Robert Sep 27, 2010 390
All change for 'pay for delay' agreements? There is now little doubt that so-called 'pay for delay' agreements, which are allegedly used by pharmaceutical and biotechnology companies to postpone the date of generic product introductions to maximize their commercial gain, could soon be restricted ... or even outlawed. Companies may wish to rethink using such agreements and revise their patent strategies accordingly. Jones, Nicholas Sep 1, 2010 855
Research and Markets: Japan Pharmaceutical Market Overview Regulatory Reforms will Stimulate Generics Uptake. Aug 31, 2010 504
Coutu braces for change. Company overview Aug 30, 2010 853
Generics keep costs down. Company rankings Aug 30, 2010 868
Questions are raised about impact of bill. Brief article Aug 30, 2010 276
Tracking Washington. Jul 5, 2010 345
Generic and brand-name AEDs bioequivalent. Evans, Jeff Jun 1, 2010 1082
Canadian coalition gears up for tough fight. Apr 26, 2010 471
Officials seek end to 'pay for delay'. Brief article Apr 26, 2010 111
Pharmacists required to offer lowest cost generic alternatives. Karapetyan, Ella Apr 7, 2010 845
Generics medicines in France: an unsuccessful legislative attempt for an exemption from trade mark rights of the appearance of substitutable generic drug tablets. Report Apr 1, 2010 334
Rx makers confront issues. Feb 15, 2010 508
U.K. moves to alter Rx substitution reg. Brief article Feb 15, 2010 301
Industry works to maintain proper balance. Feb 15, 2010 579
Pfizer Inc (New York) asked a US federal court to block Teva Pharmaceutical Industries Ltd from selling a generic form of its Zyvox antibiotic that it said would infringe a patent, according to court documents. Brief article Jan 25, 2010 203
AstraZeneca Plc, GlaxoSmithKline Plc, Sanofi-Aventis SA and other drugmakers have received queries from the European Union as part of a probe into strategies that may keep cheaper copies of medicines off the market. Jan 18, 2010 350
Zacks Analyst Blog Highlights: Citibank, KeyCorp, Ford, Abbott Laboratories Inc. and Teva Pharmaceutical Industries Ltd. Dec 4, 2009 1185
GPhA seeks change in reform bills. Nov 23, 2009 476
Tracking Washington. (TOP STORIES). Brief article Oct 19, 2009 285
Reportlinker Adds World Generics Market 2009-2024. Oct 5, 2009 2442
Health care reform or not, generics will win. Coopman, Robert Sep 28, 2009 585
Lawmakers: vital role for generics. Brief article Sep 28, 2009 208
Administration takes strong stance on biologics exclusivity. Sep 28, 2009 582
Rules for access to Rxs under development set. Sep 28, 2009 408
Biologic drug regulation examined. Sep 22, 2009 578
FTC wants 'pay-for-delay' outlawed. Anderson, Jane Aug 1, 2009 127
FTC wants to stop 'pay-for-delay'. Anderson, Jane Brief article Aug 1, 2009 167
The generic drug rip off. Faloon, William Aug 1, 2009 3952
Simple solutions can bring substantial gains. Brief article Jul 20, 2009 188
And Commissioner Margaret Hamburg said the agency wants Congress to give it leeway to decide "case by case" what data is needed to approve generic versions of biologic drugs. Jul 20, 2009 140
Biotech drug copies could be held up 13 years under Senate plan. Jul 13, 2009 366
Xanodyne Pharmaceuticals Inc. Brief article Jul 13, 2009 149
PCMA: GAO study highlights need. Brief article Jun 29, 2009 114
FTC says ending drug settlements may save $35 billion. Jun 29, 2009 373
Biotech Drugs should face generics, White House says. Brief article Jun 29, 2009 296
Court delays further action in AMP case. Brief article Jun 8, 2009 267
Topiramate approval reignites generic debate. Sullivan, Michele G. Brief article May 15, 2009 247
Two bills could alter competitive landscape. Mar 16, 2009 348
Senate to weigh bill on generics. Brief article Feb 16, 2009 120
Lawmakers to reexamine marketing of authorized generics. Feb 2, 2009 552
The Generic Pharmaceutical Association (GPhA): Kathleen Jaeger, president and CEO. Jaeger, Kathleen Jan 5, 2009 1465
Generic pharmaceutical regulation in the United States with comparison to Europe: innovation and competition. Young, Adam R. Jan 1, 2009 10049
Generic heart medicines found equal to brand-name counterparts. Brief article Dec 8, 2008 316
New PCMA Research: State Legislative Proposals Restricting Access to Generic Medicines Would Increase Costs $29 Billion Over 10 Years. Oct 2, 2008 608
President Calderon Lifts Regulation Requiring AIDS Drug Companies to Have Manufacturing Plants in Mexico in Order to Sell Generic Meds. Aug 4, 2008 336
Canadian generics makers blast legislation. Jun 30, 2008 872
Pay-for-delay tactics eyed. Jun 30, 2008 580
Biogenerics bill stirs row. Apr 28, 2008 777
Sweden: The Swedish system of generic substitution, interchangeability between reference drugs and generics. Apr 1, 2008 385
GPhA advances industry agenda. Feb 4, 2008 787
Agency's approval plan flawed. Matthews, Renee Brief article Jan 1, 2008 133
FDA aims to speed approval process. Oct 22, 2007 433
Follow-on biologics not addressed in FDA reauthorization. Napoli, Denise Oct 15, 2007 653
Provisions of biogenerics bill questioned. Schultz John Jul 23, 2007 453
Associated Food Stores Testifies in Congress Against AMP Rule. Report Jul 19, 2007 366
Biotech revolution creates challenges, opportunities. Apr 23, 2007 378
Senate to weigh generics policy. Feb 19, 2007 988
Industry has stake in trade policy. Feb 19, 2007 426
Generics help fill Part D coverge gap. Oct 23, 2006 359
System to handle ANDAs electronically. Oct 23, 2006 370
Govt lowers prices of generic drugs again. Brief article Aug 1, 2006 188
PBMs say generics thwarted. Nickell, Nancy Brief article Jun 1, 2006 207
Critics say generics thwarted. Nickell, Nancy Brief article Jun 1, 2006 210
Generic medicines--health emergency patents--EU law. Nuthall, Keith May 1, 2006 104
FTC plans to take a look at authorized generics. Dec 19, 2005 514
Waxman looks back--and into future. Oct 24, 2005 594
Use of citizen petitions becomes contentious issue. Oct 24, 2005 815
Bioshield legislation would 'increase cost of drugs'. Oct 24, 2005 341
Applications for generics set to surge. Brief Article Aug 22, 2005 272
Capital appropriations. Shorrock, Tim Brief Article Jul 1, 2005 319
Sales of generic versions of Accupril halted by court. Apr 18, 2005 412
FDA takes measure of its efforts in '04. Brief Article Apr 18, 2005 308
Patent law draws fire. Brief Article Apr 1, 2005 161
GPhA tracks global developments on regs. Brief Article Mar 28, 2005 148
Experts divided on generic biologics. Frieden, Joyce Mar 15, 2005 708
Industry plays active role in helping shape government policy. Feb 28, 2005 959
OGD performs vital regulatory, educational functions. Sep 27, 2004 690
Drug price gouging ok'd. Weissman, Robert Sep 1, 2004 1415
'Authorized products' spur debate within the industry. Aug 30, 2004 433
FDA action to spur development efforts. Apr 26, 2004 317
CGPA wants change. Brief Article Apr 1, 2004 249
Government will appeal 'shared exclusivity' ruling. Mar 15, 2004 391
Biotech. Brief Article Mar 15, 2004 132
The state of the generic drug industry. Schultz, John Feb 16, 2004 1000
New European union rules a blow to generics manufacturers. Feb 16, 2004 411
FDA first-time generics approvals--2003. Illustration Feb 16, 2004 1489
Patent expirations to bring more robust growth. Nov 24, 2003 811
Canada eyes bill to assist poor nations. Nov 24, 2003 367
New European guidelines for pharmaceutical makers draw fire. Nov 24, 2003 427
Biotechnology market proves tough to crack. (generic drug manufacturers). Brief Article Oct 27, 2003 299
Changes in Hatch-Waxman Act debated. Sep 29, 2003 510
Brazilian edict weakens patent protection. Sep 29, 2003 404
ENLARGEMENT: ACCEDING STATES DISSENT ON NEW EU MEDICINE RULES. Sep 10, 2003 307
CONTROVERSIAL AGREEMENT REACHED ON GENERIC DRUGS. Sep 5, 2003 1545
Generic drugs must meet high standards. Aug 18, 2003 388
Support grows for getting generics to market faster. Aug 18, 2003 700
Finnish spending on drugs down - report. Brief Article Jul 28, 2003 103
Getting to market faster. (Focus). Jul 21, 2003 555
APhA supports changes in policy. (Rx/Generic Drugs). Brief Article Jul 21, 2003 248
FDA acts to speed approval of generic drugs: AMA applauds action. Kirn, Timothy F. Jul 15, 2003 540
FDA acts to speed approval of generics. (Regulatory Challenges). Kirn, Timothy F. Brief Article Jul 1, 2003 272
FTC: Hatch-Waxman abused. (Focus). Jun 30, 2003 489
CMS updates list of federal upper limits. (RX: Generic Drugs). Brief Article May 19, 2003 218
PHARMACEUTICALS: GENERIC FIRMS CRITICISE PROPOSED EU RULE CHANGES. May 3, 2003 330
Generics firms on offensive. (Focus). Industry Overview Mar 17, 2003 601
Waxman calls for review of generic drug law. (Focus). Schultz, John Feb 17, 2003 850
Bush reaches out to GPhA members. (RX: Generic Drugs). Brief Article Feb 17, 2003 219
EU/WTO: MINISTERS REACH CONSENSUS ON ESSENTIAL MEDICINES. Brief Article Nov 16, 2002 706
Watching Washington: weekend transaction settlements, pharmaceutical foot-dragging, and late shipments are Capitol Hill's hot buttons for retailers. (Governments Issues). Tarnowski, Joseph Nov 15, 2002 1959
Easy access to generics. (Policy & Practice). Silverman, Jennifer Brief Article Nov 15, 2002 104
Bush moves to make generics more accessible. Nov 11, 2002 885
States join fight against drug companies for keeping generics off the market. Hellwege, Jean Nov 1, 2002 634
Reevaluating Hatch-Waxman. (Focus). Oct 28, 2002 753
FTC aims to facilitate generics' market entry. Brief Article Aug 5, 2002 622
Bill aims to speed market entry of generics. (Rx/Generic Drugs). Brief Article Feb 18, 2002 401
When should a drug be switched? (O-T-C Best-Sellers). Brief Article Jan 7, 2002 407
Red Tape Suffocating Canadian Health Care. (News Briefs/Nouvelles en Bref). Brief Article Nov 1, 2001 281
GENERIC PHARMACEUTICALS INDUSTRY KEEPS UP PRESSURE ON ACCESS. Brief Article Mar 10, 2001 408
Disputes Over Patent Extensions Grow. Brief Article Aug 28, 2000 805
FDA Gives Approval to Several Generics. Brief Article Aug 28, 2000 317
HCFA again delays action on generics. Brief Article Aug 14, 2000 167
Manufacturers Bullish After Strong '99. Brief Article Feb 28, 2000 751
FDA GRANTS APPROVAL FOR GENERIC EQUIVALENT TO IMURAN. Feb 1, 2000 188
The Outlook for Generics Makers. Feb 15, 1999 652
Let them eat erythromycin. Burstein, Rachel Brief Article Nov 1, 1997 427
Brand pharmaceutical companies continue attempts to restrict generic substitution. Downey, Bruce L. Aug 25, 1997 435
Issues for generics markers. Jul 28, 1997 659
DuPont Merck Commends Texas Patient Protection Law Jun 24, 1997 394
Bioequivalency rules sought. Jun 23, 1997 851
NPA urges Congress to help speed approval of generics. Apr 28, 1997 578
User fees for generics backed. Feb 17, 1997 818
Generics makers get boost. Aug 26, 1996 764
FDA DECISION ON GATT WILL COST CONSUMERS $6 BILLION; URGENT ACTION FOR LEGISLATION IS REQUIRED. May 25, 1995 391
Generics firms fight back. Sep 26, 1994 685
Political influence and regulatory policy: the 1984 drug legislation. Olson, Mark K. Jul 1, 1994 9435
Reform alternatives advance. Feb 28, 1994 794
Patent legislation eases generics' way. Sep 13, 1993 455
NAPM, FDA discuss speeding generic drug approval process. Jun 29, 1992 243
Generics bill under fire. Aug 27, 1990 940
Dingell rallies for support of generic drug legislation. Jul 30, 1990 206
GPIA opposed to registration fee. Jan 1, 1990 339
Congress kills Rx coverage. Oct 23, 1989 518
Revelations hurt FDA reputation; employees plead guilty. Oct 9, 1989 741
Rugby inconvenienced, but not daunted, by FDA. Oct 9, 1989 610
Probe initiated by Mylan move. Oct 9, 1989 560
Haddad continues a crusade for generic drug acceptance. Rim, Dale Jul 3, 1989 692

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters